Home - Products - Others - Other Targets - 6-Methyl-3-pyridinecarboxaldehyde

6-Methyl-3-pyridinecarboxaldehyde

CAS No. 65873-72-5

6-Methyl-3-pyridinecarboxaldehyde( —— )

Catalog No. M36398 CAS No. 65873-72-5

6-Methyl-3-pyridinecarboxaldehyde (6-Methoxynicotinaldehyde) has partial antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 26 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    6-Methyl-3-pyridinecarboxaldehyde
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Methyl-3-pyridinecarboxaldehyde (6-Methoxynicotinaldehyde) has partial antitumor activity.
  • Description
    6-Methoxypyridine-3-carbaldehyde is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65873-72-5
  • Formula Weight
    137.14
  • Molecular Formula
    C7H7NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=NC=C(C=O)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PIN1 inhibitor API-1

    PIN1 inhibitor API-1 is a specific Pin1 inhibitor (IC50: 72.3 nM). PIN1 inhibitor API-1 retains the active conformation of pXPO5 and restores the ability of pXPO5 to transport pre-miRNAs from the nucleus to cytoplasm, thus up-regulating the anticancer miRNA biogenesis to suppress both in vitro and in vivo hepatocellular carcinoma development.

  • LDC000067

    LDC000067 is a highly specific and selective CDK9 inhibitor with an IC50 value of 44±10 nM.

  • Milnacipran ((1S-cis...

    Milnacipran ((1S-cis) hydrochloride) is a serotonin-norepinephrine reuptake inhibitor (SNRI) ?treatment of fibromyalgia.